NCT00265434View on ClinicalTrials.gov

Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Cystic FibrosisChronic Rhinosinusitis
Interventions
DRUG

Pulmozyme

Trial Locations (1)

07740

Friedrich-Schiller-Universität, Jena

All Listed Sponsors
collaborator

PD Dr. Joachim Riethmöller, Tübingen

UNKNOWN

collaborator

PD Dr. Assen Koitschev, Tübingen

UNKNOWN

collaborator

Dr. Gerlind Schneider

UNKNOWN

lead

University of Jena

OTHER

NCT00265434 - Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis | Biotech Hunter | Biotech Hunter